NLM Logo

VAD regimen 2 MeSH Supplementary Concept Data 2024


MeSH Supplementary
VAD regimen 2
Unique ID
C533670
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C533670
Entry Term(s)
DD-4A regimen
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Dactinomycin
Doxorubicin
Vincristine
Frequency
3
Note
chemotherapy protocol consisting of above cpds for treatment of Wilms tumor
Source
Cancer Chemother Pharamcol 2008 Nov;62(6):1039-44
Date of Entry
2008/12/14
Revision Date
2009/02/10
VAD regimen 2 Preferred
page delivered in 0.006s